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ABSTRACT
Nasopharyngeal carriage of Streptococcus pneumoniae is a key factor in the development of invasive
disease and the spread of resistant strains within the community. A single nasopharyngeal swab was
obtained from 648 unvaccinated children aged <5 years, either healthy or with acute respiratory tract
infection or meningitis, during the winters of 2000 and 2001. The overall pneumococcal carriage rate was
35.8% (95% CI 32.1–39.6). The pneumococcal serotypes found most frequently in the nasopharynx were
14, 6B, 6A, 19F, 10A, 23F and 18C, which included ﬁve of the seven serotypes in the currently licensed
seven-valent conjugate vaccine (PCV7); serotypes 4 and 9V were less common. Serotypes 1 and 5 were
isolated rarely from the nasopharynx. A comparison of 222 nasopharyngeal isolates with 125 invasive
isolates, matched for age and time to the carrier isolates, showed a similar prevalence of penicillin
non-susceptible pneumococci (PNSp) (19.8% and 19.2%, respectively). PNSp serotypes were similar (6B,
14, 19F, 19 A, 23B and 23F) for carriage and invasive disease isolates. The coverage of PCV7 for carriage
isolates (52.2%) and invasive isolates (62.4%) did not differ signiﬁcantly (p 0.06); similarly, there was no
signiﬁcant difference in PCV7 coverage for carriage isolates (34.5%) and invasive isolates (28.2%) of
PNSp. These data suggest that PCV7 has the potential to reduce pneumococcal carriage and the number
of carriers of PNSp belonging to vaccine serotypes.
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INTRODUCTION
Asymptomatic nasopharyngeal (NP) carriage of
Streptococcus pneumoniae is prevalent in young
children and precedes the development of inva-
sive disease. Children with pneumococcal coloni-
sation act as an important vector for horizontal
spread of pneumococcal strains within the com-
munity [1,2]. There is evidence that individuals
with S. pneumoniae invasive disease carry the
same strain in their nasopharynx at the time of
invasive infection [3,4]. Consequently, pneumo-
coccal carriage strains have been used as a proxy
marker to predict drug resistance patterns and
serotype prevalence for treatment and vaccine
formulation, respectively [5,6]. In recent years,
surveillance studies have reported increased NP
colonisation by penicillin non-susceptible pneu-
mococci (PNSp) [7,8]. The currently licensed
seven-valent conjugate vaccine (PCV7), and other
formulations of pneumococcal conjugate vaccines,
confer protection against invasive disease caused
by both susceptible pneumococci and PNSp [9].
Also, conjugate vaccines seem to be useful for
reducing the carriage of vaccine-related sero-
types, and could therefore decrease dissemination
of PNSp in the community [10–12].
Data concerning serotypes causing invasive
pneumococcal disease (IPD), as well as the
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serotypes of NP carriage isolates, in developing
countries are scarce. In Latin America, the fre-
quency of invasive serotypes differs from that
found in many other parts of the world, whereas
no major difference has been found in the fre-
quency of NP serotypes compared with other
countries [13–15]. In Brazil, the country with the
largest child population in Latin America, no
previous study has compared the serotypes of
pneumococcal carriage and IPD isolates, which
could help to predict the future impact of the
universal childhood conjugate vaccination pro-
gramme. Therefore, the present study compared
the penicillin susceptibility and serotype distri-
bution of NP and IPD isolates. In addition, the
potential coverage of the pneumococcal conjugate
vaccines with respect to carriage serotypes was
estimated in a population without previous pneu-
mococcal immunisation.
MATERIALS AND METHODS
Study site and selection of participants
The investigation was conducted in the municipality of
Goiaˆnia (1 090 581 inhabitants), Central Brazil, as part of an
ongoing prospective surveillance of S. pneumoniae and Haemo-
philus inﬂuenzae among children. The surveillance was carried
out during the winter periods (18–21C) of 2000 and 2001
(May–August) at 20 large paediatric hospitals in Goiaˆnia.
Children, aged <5 years, admitted with acute respiratory tract
infection (including pneumonia) and meningitis, and also
healthy children who attended the local childcare programme,
were eligible. Children with underlying chronic illness,
including immunological, renal, cardiac, hepatic or haemato-
logical diseases, were excluded. Parents were interviewed by
trained health workers who were unaware of each child’s
carrier status. Information concerning demographic and
clinical characteristics was recorded. In total, 648 children
were studied; the sample size was calculated to detect a 30%
prevalence of NP pneumococcal carriage (a error ± 5%) and an
estimated 20% prevalence of PNSp (a error ± 5%). The study
protocol was approved by the Regional Ethical Committee
from the Federal University of Goia´s; all guardians of the
participating children gave informed consent.
Collection of NP swabs and microbiological procedures
NP swabs were collected from children with respiratory tract
infection (RTI) and meningitis at the time of hospital admis-
sion. NP swabs were also collected from healthy children who
attended the local childcare programme. NP specimens were
collected with pernasal, extra-thin, ﬂexible, calcium alginate
swabs, then placed in Stuart transport medium tubes (Tran-
swab; Medical Wire and Equipment, Corsham, UK) and
transferred to the Laboratory of Bacteriology of the Federal
University of Goia´s within 6 h of collection, according to WHO
standard methods [16]. S. pneumoniae was identiﬁed using
standard laboratory procedures, including morphology fol-
lowing Gram’s stain, susceptibility to a 5-lg optochin disk, and
the bile solubility test. Isolates were preserved at ) 80C.
Penicillin breakpoints and MICs were determined and inter-
preted according to NCCLS guidelines [17]. Serotyping was
performed at the Adolfo Lutz Institute (Sa˜o Paulo, Brazil) by
Quellung reactions with standard antisera (Statens Serumin-
stitut, Copenhagen, Denmark).
Data analysis
A single nasopharyngeal specimen was obtained per child. For
comparison purposes, 125 invasive isolates were selected,
matched for age and time to the carrier isolates; the invasive
isolates were retrieved mainly from cerebrospinal ﬂuid of
children admitted to public and private paediatric hospitals in
Goiaˆnia. The invasive pneumococci were isolated at each
participating local hospital and then sent to the National
Reference Center for S. pneumoniae (Adolfo Lutz Institute) for
species conﬁrmation, serotyping and susceptibility testing, as
described previously [18]. The concordance between the
serotypes included in the formulations of the PCV7, nine-
(PCV9) and 11- (PCV11) valent conjugate vaccines and the NP
and IPD isolates was used as an indicator of the serotype cov-
erage of each conjugate vaccine. For the purposes of analysis,
PNSp isolates were considered to include the intermediately-
resistant isolates (MIC 0.1–1.0 mg ⁄L) and the fully-resistant
isolates (MIC ‡ 2.0 mg ⁄L). Data analysis was performed using
Epi-Info 6.04 and SPSS v.10.0 (SPSS Inc., Chicago, IL, USA).
Categorical data were compared using the chi-square (v2) or
Fisher’s exact test, as appropriate, with p < 5% (two-tailed)
considered to be statistically signiﬁcant.
RESULTS
Most participants were children aged <24 months
(mean 13.8 ± 9.5 months), with males accounting
for 53.2% of the study population. Almost half
(46.6%) were healthy infants, while children with
co-morbidity (RTI and meningitis) represented
53.4% of the participants. In total, 146 (24.5%)
children had received antibiotics previously,
mainly b-lactams (amoxycillin-clavulanate). Chil-
dren with co-morbidity had a higher prevalence of
previous antibiotic use (37.6%; 95% CI 32.1–
43.3%) than did healthy children (10.7%; 95% CI
7.4–14.8%). A small proportion of children (5.4%)
were attending day-care centres. The overall
pneumococcal carriage rate was 35.8% (95% CI
32.1–39.6%), with a signiﬁcantly higher preva-
lence of carriage among healthy children (41.4%)
compared to those with co-morbidity (30.9%;
p < 0.05). The mean age of children with pneu-
mococcal carriage (14.1 ± 9.7 months) and chil-
dren who were non-carriers (13.6 ± 9.5 months)
was statistically similar.
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The most frequent pneumococcal serotypes
found in the nasopharynx were 14, 6B, 6A, 19F,
10A, 23F and 18C, which included ﬁve of the
seven serotypes in PCV7; serotypes 4 and 9V were
less common (Table 1). Serotypes 1 (0.5%) and 5
(0.9%) were isolated rarely from the nasophar-
ynx, and ranked 13th (0.8%) and 5th (5.6%),
respectively, among children with IPD. No signi-
ﬁcant difference was found in PCV7 coverage
between the carriage serotypes and IPD sero-
types, but the coverage of carriage isolates by the
PCV9 and PCV11 vaccines was statistically lower
than the coverage of IPD isolates (Table 2).
The PNSp serotypes were the same (6B, 14, 19F,
19A, 23B and 23F) for carriage and IPD isolates,
with a predominance of serotypes 6B and 14,
which together accounted for 63.7% (NPD) and
70.8% (IPD) of PNSp isolates. Among the 227
carriage isolates tested for penicillin susceptibil-
ity, 19.8% (95% CI 14.8–25.6%) were PNSp,
compared with 19.2% (95% CI 12.7–27.2%) of
125 isolates from IPD. Similar proportions of
healthy children and children with RTI were
carriers of PNSp isolates (20.9% and 18.7%,
respectively; p > 0.05). The proportion of PNSp
carriage covered by the PCV7, PCV9 and PCV11
vaccines was 34.5%, 33.6% and 31.5%, respect-
ively. No statistical difference was observed in
PCV7 coverage of PNSp when comparing car-
riage (34.5%; 95% CI 25.9–43.9%) and IPD
(28.2%; 95% CI 18.6–39.5%) isolates.
DISCUSSION
A prevalence of 35.8% for pneumococcal NP
carriage was found among children in central
Brazil, which is signiﬁcantly lower than that
reported (55%) in a less-developed region of the
country [19]. Brazil has a continental dimension,
with pocket regions of socio-economic depriva-
tion; therefore, results obtained in a particular
region cannot be generalised to the country as a
whole. It has been well-illustrated that pneumo-
coccal carriage rates vary substantially in different
areas of the world, depending upon geographic
and socio-economic conditions [1]. The present
study found that healthy children had higher
pneumococcal NP carriage rates than did children
with co-morbidity, which is consistent with the
previous Brazilian report [19]. One possible
explanation for these ﬁndings is the high usage
of antimicrobial agents before hospitalisation
among children with RTI [20].
The serotype distribution among NP isolates in
the present investigation was similar to that
found in previous studies in Brazil, the USA
and other countries of Latin America and Europe
[1,13,19]. Overall, the serotypes isolated from the
nasopharynx included the most common sero-
types causing invasive disease, with most being
represented in the PCV7. The non-vaccine sero-
types 6A and 19A, believed to show cross-reac-
tivity with PCV7 [21], were also isolated in
substantial proportions from the nasopharynx.
Therefore, ﬁve and four serotypes would in-
clude 54% of carriage and invasive isolates,
Table 1. Streptococcus pneumoniae in nasopharynx and in
invasive disease of children, ranked by frequency of
serotypes
Nasopharynx isolates (n=222) Invasive disease isolates (n=125)
Serotypes No. ( %)
PNSp
(n = 44)
No. (%) Serotypes No. ( %)
PNSp
(n = 24)
No. (%)
14 33 (14.9) 12 (27.3) 14 26 (20.8) 9 (37.5)
6B 29 (13.1) 16 (36.4) 6B 18 (14.4) 8 (33.3)
6A 24 (10.8) – 18C 14 (11.2) –
19F 19 (8.6) 6 (13.6) 19F 10 (8.0) 3 (12.5)
10A 15 (6.8) – 5 7 (5.6) –
23F 14 (6.3) 6 (13.6) 23F 6 (4.8) 2 (8.3)
18C 11 (5.0) – 4 5 (4.0) –
19A 10 (4.5) 3 (6.8) 6A 5 (4.0) –
9N 9 (4.0) – 9V 4 (3.2) – -
18A 9 (4.0) 18B 4 (3.2)
9V 8 (3.6) – 9N 3 (2.4) –
11A 6 (2.7) – 10A 3 (2.4) –
15B 6 (2.7) – 19A 3 (2.4) 1 (4.2)
7F 5 (2.3) – 7C 2 (1.6) –
3 3 (1.3) – 7F 2 (1.6) –
23A 3 (1.3) – 8 2 (1.6) –
4 2 (0.9) – 12F 2 (1.6) –
5 2 (0.9) – Othersc 9 (7.2) 1 (4.2)b
12 2 (0.9) –
18B 2 (0.9) –
22F 2 (0.9) –
Others a 8 (3.6) 1 (2.3)b
aserotypes 1, 7B, 7C, 8, 10F, 11, 22, 23B.
bserotype 23B.
cserotypes 1, 15B, 17F, 18A, 18F, 23B, 27, 28A, 34.
Table 2. Vaccine coverage of Streptococcus pneumoniae
serotypes identiﬁed among carriage and invasive disease
isolates
Vaccine
Carriage isolates Invasive disease isolates
n = 222 % (95% CI) n = 125 % (95% CI)
7-valent vaccine serotypesa 116 52.2 (45.5–59.0)d 78 62.4 (53.3–70.9)d
9-valent vaccine serotypesb 119 53.6 (46.8–60.3)e 86 68.8 (59.9–76.8)e
11-valent vaccine serotypesc 127 57.2 (50.4–63.8)e 87 69.6 (60.7–77.5)e
aSerotypes 4, 6B, 9V, 14, 18C, 19F, 23F.
b7-valent serotypes + serotypes 1 and 5.
c9-valent serotypes + serotypes 3 and 7F.
dp 0.06.
ep < 0.05.
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respectively. In the USA and UK, only three and
two serotypes, respectively, accounted for 50% of
cases of IPD [22,23]. In contrast, a wide variety of
pneumococcal serotypes has been associated with
NP carriage in Asia, as well as with invasive
disease [15,24]. These ﬁndings underscore the
importance of pneumococcal NP colonisation in
the development of community infection in some
geographical regions.
The present study found that serotypes 1 and 5
were rare among NP carriage isolates, in contrast
to the high prevalence of serotype 5 among the
isolates causing paediatric invasive disease. Sero-
type 1 has been associated frequently with cases
of pneumonia [18,25], and the small number of
such cases represented among the present collec-
tion of IPD isolates has probably prevented more
frequent detection of this serotype. It has been
well-documented that serotypes 1 and 5 are
among the most common IPD serotypes in Brazil
and many other regions of the world, including
developing and developed countries [14,18,26–
29]. It has been hypothesised that, because of their
virulence, serotypes 1 and 5 have a transient and
fast passage through the nasopharynx before
reaching the blood stream [30]. These assump-
tions agree with a recent meta-analysis, which
provided evidence for a statistically signiﬁcant
inverse relationship between pneumococcal inva-
siveness and carriage prevalence, since serotypes
1 and 5 had the highest OR for being invasive and
the lowest prevalence of NP colonisation [31].
Of note is the frequency of the non-vaccine
serotype 10A among NP carriage and IPD isolates
in the present dataset. Previous studies in some
countries of Latin America [13] and other devel-
oped countries [1,32–34] have identiﬁed 10A as a
frequent serotype among carriage and IPD iso-
lates, although this has not been the case in other
developing regions [15,35]. These observations
emphasise the importance of continued monitor-
ing of the regional prevalence of serotypes to
predict the appropriate vaccine for a particular
region or country as a whole.
The same frequency of PNSp (19%) was found
among NP and IPD isolates, which endorses the
assumption that the frequency of PNSp among
NP isolates from children could be used as a
surrogate indicator for the resistance rate among
IPD isolates for the same region and period
[1,5,36]. As shown previously [10], the frequency
with which particular serotypes were isolated
from the nasopharynx and from sterile ﬂuids in
the present study population was associated with
their likelihood to become penicillin-resistant,
which supports the hypothesis that PNSp isolates
are limited to a few serotypes (6B, 14, 19F, 23F,
19A) that frequently colonise children and cause
paediatric infections [7,8].
Several recent publications have reported the
effect of conjugate vaccines on the carriage of
PNSp. Replacement of carriage serotypes with
non-vaccine types (NVTs), which could acquire
antibiotic resistance, is a matter of concern. In
Israel, PCV9 reduced the carriage rate of PNSp by
24%, but increased the carriage of NVTs (usually
penicillin-susceptible), leading to an overall
reduction in carriage of PNSp [11]. In contrast, a
reduction in the carriage of penicillin-resistant
vaccine-type (VT) strains was observed following
use of PCV7 in Portugal, but with an emergence
of resistance in NVTs [37]. The decrease in the
overall carriage of PNSp strains in vaccinated
individuals was therefore not signiﬁcant com-
pared with the control group, and it was sugges-
ted that a reduction in the carriage of PNSp
strains might require a combination of use of the
conjugate vaccine and a decrease in antibiotic
pressure. In Alaska, no impact on carriage of
PNSp was observed after the introduction of
PCV7 into the routine vaccination schedule [38].
The results of the present investigation suggest
that the potential beneﬁt, in terms of the reduction
in carriage rate of PNSp, would be similar
(c. 33%), regardless of the vaccine formulation,
as serotypes 1 and 5 (PCV9) and 3 and 7F (PCV11)
are not usually associated with penicillin resist-
ance [29].
These ﬁndings highlight the importance of
monitoring pneumococcal NP carriage as an
indicator of penicillin susceptibility in settings
where isolation of invasive pneumococcal isolates
is difﬁcult. In addition, continued surveillance of
the distribution of serotypes among colonising
isolates provides a baseline for further assessment
of the impact of vaccination, particularly in
regions, such as Brazil, where the introduction
of pneumococcal conjugate vaccine is feasible.
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